Updates

February 18, 2019February 18, 2019
Plant Compound Emodin Could be Used as Treatment for AS, Study Says

Emodin, a plant compound used in traditional Chinese medicine, has potent anti-inflammatory and anti-rheumatic properties that, when combined with autophagy inhibitors, may be a ... Read more
February 13, 2019February 13, 2019
Tiny RNA Molecule a Potential Diagnostic Biomarker for Ankylosing Spondylitis, Study Says

Levels of a tiny RNA molecule, called miR-214, correlate with ankylosing spondylitis disease activity and may be used as a noninvasive biomarker in ... Read more
February 13, 2019February 12, 2019
How to Stay Informed About Ankylosing Spondylitis

I’m a wellness writer and editor. Some of my work has appeared in publications including The New York Times, Good Housekeeping, and here at ... Read more
February 11, 2019February 11, 2019
Risk for Dementia Higher in Ankylosing Spondylitis Patients, Study Suggests

The risk for developing overall dementia and Alzheimer’s disease dementia is higher in patients with ankylosing spondylitis (AS), according to a nationwide study ... Read more
February 11, 2019
Patients, Family and Friends to Take Part in Variety of Rare Disease Day Events Worldwide

Scores of events are afoot worldwide to mark Feb. 28, Rare Disease Day 2019. The activities aim to raise awareness about rare diseases and the millions ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

News

Two Bone Metabolism-related Proteins May Help Determine Ankylosing Spondylitis Risk, Study Suggests
February 6, 2019February 6, 2019
Determining blood levels of two proteins — osteoprotegerin (OPG) and receptor activator of nuclear ...
News

TNF Inhibitors Improve Bone Mineral Density but Not Vertebral Fractures in AS Patients, Study Says
February 4, 2019February 4, 2019
Long-term treatment with TNF-alpha inhibitors improves bone mineral density (BMD) but does not affect ...
News

Levels of RNA Molecule a Potential Biomarker for Ankylosing Spondylitis, Study Suggests
January 30, 2019January 30, 2019
Analyzing the circulating levels of a specific RNA molecule, known as MEG3, may be used as ...
News

Ankylosing Spondylitis Patients Have Lower Health-Related Quality of Life, Study Shows
January 28, 2019January 28, 2019
People with ankylosing spondylitis have diminished health-related quality of life (HRQoL) compared to the ...
A Wellness Journey - a Column by Lisa Marie Basile, Columns

Attending My First Ankylosing Spondylitis Meetup
January 23, 2019January 25, 2019
I was anxious as I walked into my first ankylosing spondylitis meetup, sponsored by ...
News

TNF-Alpha Blocking Therapy Can Ease Hip Issues in AS Patients, Study Suggests
January 21, 2019January 21, 2019
Approximately 10 to 23 percent of people with ankylosing spondylitis have hip joint involvement ...

Risk of Atrial Fibrillation Increases in Certain Ankylosing Spondylitis Patients, Study Finds
January 9, 2019January 9, 2019
Ankylosing spondylitis (AS) patients younger than 40 and those treated with tumor necrosis factor ...
This Beautiful Documentary Does Justice to Those with Ankylosing Spondylitis
January 9, 2019January 8, 2019
When I search for “autoimmune disease” or “immune-mediated disease” on YouTube, I get a ...
Simponi Lowers Incidence of Acute Anterior Uveitis, Phase 4 Study Shows
January 7, 2019January 7, 2019
Novartis, TrialSpark Collaborate to Maximize Patient Access to Clinical Trials, Therapy Development
January 2, 2019January 2, 2019
Rising Healthcare Costs Strain EU Budgets Even as New Therapies Flourish
December 20, 2018December 20, 2018
Using Aqua Workouts to Soothe Ankylosing Spondylitis Pains
December 19, 2018December 18, 2018

My Ankylosing Spondylitis Diagnosis Journey, Part 2
December 12, 2018January 7, 2019
Second in a series. Read part one. And then the symptoms hit. By 30, ...
The Joys and Perils of Turning to Online Groups for Support
December 5, 2018December 4, 2018
TNF-alpha Inhibitors May Increase Eosinophil Levels in Ankylosing Spondylitis Patients, Study Suggests
December 3, 2018December 3, 2018
My Ankylosing Spondylitis Diagnosis Journey, Part 1
November 28, 2018January 7, 2019

Genetic Marker HLA-B27 Correlates With Ankylosing Spondylitis Onset but Not Disease Burden, Study Shows
November 26, 2018November 26, 2018
The presence of a specific genetic marker called HLA-B27 in Caucasian ankylosing spondylitis patients is related to ...
Phase 3 Trial Evaluating Xeljanz’s Efficacy in Patients with Active Ankylosing Spondylitis Now Enrolling
November 12, 2018November 12, 2018
Ixekizumab Benefits Ankylosing Spondylitis Patients Who Failed to Respond to Standard Therapy, Phase 3 Study Shows
November 5, 2018November 5, 2018

News

#NORDSummit – Major Issues on Table for Rare Disease Patients in US as Midterm Elections Approach
October 31, 2018October 29, 2018
With the U.S. midterm elections now less than two weeks away, patient advocacy groups ...
News

Anti-Rheumatic or Anti-Tumor Necrosis Therapy Does Not Contribute to Increased Infection Risk, Study Shows
October 29, 2018October 29, 2018
Patients with ankylosing spondylitis treated with anti-rheumatic drugs or anti-tumor necrosis therapy are not ...
News

Filgotinib Safe, Effective in Treating Ankylosing Spondylitis, Phase 2 Trial Shows
October 24, 2018October 24, 2018
Filgotinib, an investigational therapy for ankylosing spondylitis (AS) and other inflammatory diseases, was able to ...
News

Cosentyx Safe, Effective Through 5 Years of Treatment, Novartis Announces
October 17, 2018October 17, 2018
Five-year treatment with Cosentyx (secukinumab) is safe and effective in easing signs and symptoms of ankylosing ...
News

Low Levels of Specific Immune Cell Linked to Ankylosing Spondylitis Manifestations, Mouse Study Suggests
October 15, 2018October 15, 2018
Malfunction of the ankylosing spondylitis-associated gene, ERAP1, is connected to the loss of a certain ...
A Wellness Journey - a Column by Lisa Marie Basile, Columns

3 Reasons to Be Thankful for Your AS Experience
October 10, 2018October 10, 2018
Following my ankylosing spondylitis (AS) diagnosis, I thought the world had ended. I felt ...

March 7, 2018March 7, 2018

Cosentyx Leads to Long-Term Improvement in AS Patients, Phase 3 Trial Shows

News

Results from a Phase 3 clinical trial show that treatment with Cosentyx (secukinumab) led to fast, significant, and sustained symptom improvement in patients with active ankylosing spondylitis (AS). Improvements were particularly noticeable in patients who had never ... Read more

Subscribe to our mailing list

Pin It on Pinterest